Fragmentomic analysis of circulating tumor DNA-targeted cancer panelsKyle T. Helzer, Shuang G. Zhao, Marina N. Sharifi et al.|Annals of Oncology|2023Cited by 70
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate CancerJamie M. Sperger, Joshua M. Lang, Kyle T. Helzer et al.|Clinical Cancer Research|2023Cited by 56
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical OutcomesMarina N. Sharifi, Joshua M. Lang, Jamie M. Sperger et al.|Cancer Discovery|2025Cited by 16
Abstract B016: Liquid biopsy biomarker analysis of a phase II trial of sacituzumab govitecan in castrate resistant metastatic prostate cancerJamie M. Sperger, Joshua M. Lang, Amy K. Taylor et al.|Cancer Research|2023Cited by 4
Fragmentomics of cell-free DNA from targeted panels in genitourinary malignancies.Amy K. Taylor, Shuang G. Zhao, Kyle T. Helzer et al.|Journal of Clinical Oncology|2024Cited by 1